These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 26976923)

  • 1. Response to Letter Regarding Article, "Upregulation of K2P3.1 K+ Current Causes Action Potential Shortening in Patients With Chronic Atrial Fibrillation".
    Schmidt C; Wiedmann F; Voigt N; Zhou XB; Heijman J; Lang S; Albert V; Kallenberger S; Ruhparwar A; Szabó G; Kallenbach K; Karck M; Borggrefe M; Biliczki P; Ehrlich JR; Baczkó I; Lugenbiel P; Schweizer PA; Donner BC; Katus HA; Dobrev D; Thomas D
    Circulation; 2016 Mar; 133(11):e440-1. PubMed ID: 26976923
    [No Abstract]   [Full Text] [Related]  

  • 2. Letter by Olschewski et al Regarding Article, "Upregulation of K2P3.1 K+ Current Causes Action Potential Shortening in Patients With Chronic Atrial Fibrillation".
    Olschewski A; Chandran N; Olschewski H
    Circulation; 2016 Mar; 133(11):e439. PubMed ID: 26976922
    [No Abstract]   [Full Text] [Related]  

  • 3. Upregulation of K(2P)3.1 K+ Current Causes Action Potential Shortening in Patients With Chronic Atrial Fibrillation.
    Schmidt C; Wiedmann F; Voigt N; Zhou XB; Heijman J; Lang S; Albert V; Kallenberger S; Ruhparwar A; Szabó G; Kallenbach K; Karck M; Borggrefe M; Biliczki P; Ehrlich JR; Baczkó I; Lugenbiel P; Schweizer PA; Donner BC; Katus HA; Dobrev D; Thomas D
    Circulation; 2015 Jul; 132(2):82-92. PubMed ID: 25951834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inverse remodelling of K2P3.1 K+ channel expression and action potential duration in left ventricular dysfunction and atrial fibrillation: implications for patient-specific antiarrhythmic drug therapy.
    Schmidt C; Wiedmann F; Zhou XB; Heijman J; Voigt N; Ratte A; Lang S; Kallenberger SM; Campana C; Weymann A; De Simone R; Szabo G; Ruhparwar A; Kallenbach K; Karck M; Ehrlich JR; Baczkó I; Borggrefe M; Ravens U; Dobrev D; Katus HA; Thomas D
    Eur Heart J; 2017 Jun; 38(22):1764-1774. PubMed ID: 28057773
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cloning, functional characterization, and remodeling of K2P3.1 (TASK-1) potassium channels in a porcine model of atrial fibrillation and heart failure.
    Schmidt C; Wiedmann F; Langer C; Tristram F; Anand P; Wenzel W; Lugenbiel P; Schweizer PA; Katus HA; Thomas D
    Heart Rhythm; 2014 Oct; 11(10):1798-805. PubMed ID: 24952150
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of cardiac two-pore-domain K+ (K2P) channels--an emerging antiarrhythmic concept.
    Schmidt C; Wiedmann F; Schweizer PA; Katus HA; Thomas D
    Eur J Pharmacol; 2014 Sep; 738():250-5. PubMed ID: 24927994
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic variation in the two-pore domain potassium channel, TASK-1, may contribute to an atrial substrate for arrhythmogenesis.
    Liang B; Soka M; Christensen AH; Olesen MS; Larsen AP; Knop FK; Wang F; Nielsen JB; Andersen MN; Humphreys D; Mann SA; Huttner IG; Vandenberg JI; Svendsen JH; Haunsø S; Preiss T; Seebohm G; Olesen SP; Schmitt N; Fatkin D
    J Mol Cell Cardiol; 2014 Feb; 67():69-76. PubMed ID: 24374141
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stretch-activated two-pore-domain (K
    Schmidt C; Wiedmann F; Kallenberger SM; Ratte A; Schulte JS; Scholz B; Müller FU; Voigt N; Zafeiriou MP; Ehrlich JR; Tochtermann U; Veres G; Ruhparwar A; Karck M; Katus HA; Thomas D
    Prog Biophys Mol Biol; 2017 Nov; 130(Pt B):233-243. PubMed ID: 28526353
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impaired Na⁺-dependent regulation of acetylcholine-activated inward-rectifier K⁺ current modulates action potential rate dependence in patients with chronic atrial fibrillation.
    Voigt N; Heijman J; Trausch A; Mintert-Jancke E; Pott L; Ravens U; Dobrev D
    J Mol Cell Cardiol; 2013 Aug; 61():142-52. PubMed ID: 23531443
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TASK-1 and TASK-3 may form heterodimers in human atrial cardiomyocytes.
    Rinné S; Kiper AK; Schlichthörl G; Dittmann S; Netter MF; Limberg SH; Silbernagel N; Zuzarte M; Moosdorf R; Wulf H; Schulze-Bahr E; Rolfes C; Decher N
    J Mol Cell Cardiol; 2015 Apr; 81():71-80. PubMed ID: 25655935
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TREK-1 (K
    Lugenbiel P; Wenz F; Syren P; Geschwill P; Govorov K; Seyler C; Frank D; Schweizer PA; Franke J; Weis T; Bruehl C; Schmack B; Ruhparwar A; Karck M; Frey N; Katus HA; Thomas D
    Basic Res Cardiol; 2017 Jan; 112(1):8. PubMed ID: 28005193
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cardiac two-pore-domain potassium channels (K2P): Physiology, pharmacology, and therapeutic potential].
    Schmidt C; Wiedmann F; Schweizer PA; Katus HA; Thomas D
    Dtsch Med Wochenschr; 2012 Aug; 137(33):1654-8. PubMed ID: 22875694
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic atrial fibrillation increases microRNA-21 in human atrial myocytes decreasing L-type calcium current.
    Barana A; Matamoros M; Dolz-Gaitón P; Pérez-Hernández M; Amorós I; Núñez M; Sacristán S; Pedraz Á; Pinto Á; Fernández-Avilés F; Tamargo J; Delpón E; Caballero R
    Circ Arrhythm Electrophysiol; 2014 Oct; 7(5):861-8. PubMed ID: 25107449
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The two-pore domain potassium channel, TWIK-1, has a role in the regulation of heart rate and atrial size.
    Christensen AH; Chatelain FC; Huttner IG; Olesen MS; Soka M; Feliciangeli S; Horvat C; Santiago CF; Vandenberg JI; Schmitt N; Olesen SP; Lesage F; Fatkin D
    J Mol Cell Cardiol; 2016 Aug; 97():24-35. PubMed ID: 27103460
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiac expression and atrial fibrillation-associated remodeling of K₂p2.1 (TREK-1) K⁺ channels in a porcine model.
    Schmidt C; Wiedmann F; Tristram F; Anand P; Wenzel W; Lugenbiel P; Schweizer PA; Katus HA; Thomas D
    Life Sci; 2014 Mar; 97(2):107-15. PubMed ID: 24345461
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel ion channel targets in atrial fibrillation.
    Hancox JC; James AF; Marrion NV; Zhang H; Thomas D
    Expert Opin Ther Targets; 2016 Aug; 20(8):947-58. PubMed ID: 26918581
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Physiological and pathophysiological roles of the KCNK3 potassium channel in the pulmonary circulation and the heart.
    Saint-Martin Willer A; Santos-Gomes J; Adão R; Brás-Silva C; Eyries M; Pérez-Vizcaino F; Capuano V; Montani D; Antigny F
    J Physiol; 2023 Sep; 601(17):3717-3737. PubMed ID: 37477289
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early electrical remodeling in rabbit pulmonary vein results from trafficking of intracellular SK2 channels to membrane sites.
    Ozgen N; Dun W; Sosunov EA; Anyukhovsky EP; Hirose M; Duffy HS; Boyden PA; Rosen MR
    Cardiovasc Res; 2007 Sep; 75(4):758-69. PubMed ID: 17588552
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atrial remodeling and atrial fibrillation: mechanisms and implications.
    Nattel S; Burstein B; Dobrev D
    Circ Arrhythm Electrophysiol; 2008 Apr; 1(1):62-73. PubMed ID: 19808395
    [No Abstract]   [Full Text] [Related]  

  • 20. Pitx2c increases in atrial myocytes from chronic atrial fibrillation patients enhancing IKs and decreasing ICa,L.
    Pérez-Hernández M; Matamoros M; Barana A; Amorós I; Gómez R; Núñez M; Sacristán S; Pinto Á; Fernández-Avilés F; Tamargo J; Delpón E; Caballero R
    Cardiovasc Res; 2016 Mar; 109(3):431-41. PubMed ID: 26714926
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.